Mpox

Mpox is an exotic infectious disease caused by the Mpox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. A fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms in humans. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.

Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention

The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

In the wake of the global Mpox outbreak in non-endemic countries in 2022, the medical community has been searching for safer and more efficient ways to transport and test virus samples, especially from patients in areas with limited biological containment facilities.

From Medical Wire 6 Sep 2024

Study finds Lassa fever infection rates to be far greater than previously believed

The first-ever detailed estimate of the real damage done by Lassa fever, a virus endemic to West Africa, has found that it infects 2.7 million people a year, ten times more than health agencies had assumed.

4 Sep 2024

UNICEF issues emergency tender for mpox vaccine procurement

UNICEF today announced that it has issued an emergency tender for the procurement of mpox vaccines. Vaccines can play a critical role in containing the mpox outbreak which was declared a public health emergency by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO).

2 Sep 2024

Study identifies key predictors of severe mpox cases

The study uncovers factors influencing mpox severity and duration, emphasizing the role of viral load and specific clinical presentations in patient outcomes.

2 Sep 2024

Nigeria and DRC take action with new mpox vaccine rollouts

Nigeria is to begin the immediate rollout of 5,000 doses of mpox vaccines while the Democratic Republic of Congo (DRC) eyes its first shipment of 65,000 doses, as Africa steps up measures to control the multi-country outbreak.

30 Aug 2024

Mpox persists in England: Strong vaccine effectiveness, stay vigilant

Study found that mpox cases in England remained low but steady in 2023, with the MVA-BN vaccine showing 82% effectiveness in preventing severe disease, particularly among GBMSM.

29 Aug 2024

WHO calls for manufacturers to submit mpox diagnostic tests for Emergency Use Listing

WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL).

29 Aug 2024

Healthcare workers unprepared for mpox outbreak due to knowledge gaps and vaccine inequity

Research highlights significant gaps in healthcare workers' knowledge of mpox during the 2022-2023 outbreaks, emphasizing the need for better global preparedness and equitable vaccine access.

27 Aug 2024

WHO launches global plan to stop human-to-human transmission of mpox

The World Health Organization (WHO) today launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts.

26 Aug 2024

New Mpox strain sparks global health alert

On Wednesday, August 14th, 2024, in response to the active circulation of clade 1 monkeypox virus (MPXV) in Central Africa and the recent expansion of a subtype (1b) thought to be more lethal and transmissible in East Africa, the World Health Organization (WHO) declared a public health emergency of international concern (PHEIC), paving the way for enhanced coordination between regional health systems and the active engagement of stakeholders to tackle this global outbreak. The following day, Thursday August 15, Sweden reported the first positive case of clade 1b mpox on European soil. This led the French government to place the French health system on maximum alert on Friday, August 16, and the French authorities have now begun to re-evaluate the health recommendations established in 2022 during the previous mpox outbreak in preparation for the probable emergence of cases in the country.

23 Aug 2024

Responding to Mpox: Global outbreak, research innovations, and therapeutic strategies

In August 2024, the WHO declared Mpox (formerly known as Monkeypox) a global health emergency due to rising Clade I Mpox cases in Africa and Sweden, highlighting the urgency for coordinated global efforts to monitor and mitigate the spread of the virus.

From Sino Biological Inc. 22 Aug 2024

First meeting of the International Health Regulations Emergency Committee reports on mpox surge

The Director-General of the World Health Organization (WHO), having concurred with the advice offered by the International Health Regulations (2005) (IHR or Regulations) Emergency Committee regarding the upsurge of mpox 2024 during its first meeting, held on 14 August 2024, has determined, on the same date, that the ongoing upsurge of mpox in the Democratic Republic of the Congo (DRC) and in a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the provisions of the Regulations.

20 Aug 2024

Tecovirimat shows no significant impact on mpox lesion duration in DRC study

The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on an initial analysis of data from a randomized, placebo-controlled trial.

16 Aug 2024

WHO declares international health emergency as mpox spreads rapidly in Africa

WHO has declared the upsurge of mpox in the DRC and other African countries as a public health emergency of international concern, citing its potential for further spread and the urgent need for coordinated global action.

15 Aug 2024

WHO considers declaring mpox outbreak a Public Health Emergency of International Concern

The WHO is poised to activate its last-resort alarm for the growing mpox outbreak in central Africa by declaring it a Public Health Emergency of International Concern (PHEIC) - with the committee responsible for the decision meeting on Wednesday.

13 Aug 2024

Survey: Most people unaware of cooling center locations despite increasing heat wave frequency

With NASA data showing that July 22, 2024, was the hottest day on record and indications that July may have been the hottest month, an Annenberg Public Policy Center survey conducted in mid-July found that most people know three of the symptoms of a heat-related illness but do not know the location of their nearest cooling center.

9 Aug 2024

Renewed mpox threat finds public unprepared

It has been two years since the World Health Organization declared a global health emergency over an outbreak of mpox, a disease endemic to Africa that had spread to scores of countries. Now, in the summer of 2024, a deadlier version of the infectious disease has spread from the Democratic Republic of Congo to other African nations, the strain that originally hit the United States has shown signs of a resurgence, and this week the Centers for Disease Control and Prevention (CDC) issued a new alert on mpox to health care providers.

9 Aug 2024

Priority pathogens selected for wastewater surveillance during Paris 2024 Olympic and Paralympic Games

The study by researchers from the French national public health institute aimed to identify priority pathogens that could be suitable for wastewater surveillance (WWS) during the Paris 2024 Olympic and Paralympic Games taking place from 26 July to 11 August and 28 August to 8 September, respectively.

12 Jul 2024

New deadly strain of mpox found in DRC could spread exponentially among humans

Concerns are growing about an outbreak of deadly mpox caused by a novel, sexually transmitted strain of the virus in the southeast of the Democratic Republic of Congo (DRC).

5 Jul 2024

‘We’re flying blind’: CDC has 1M bird flu tests ready, but experts see repeat of covid missteps

It's been nearly three months since the U.S. government announced an outbreak of the bird flu virus on dairy farms.

20 Jun 2024

Mpox

Overview

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

Study finds Lassa fever infection rates to be far greater than previously believed

UNICEF issues emergency tender for mpox vaccine procurement

Study identifies key predictors of severe mpox cases

Nigeria and DRC take action with new mpox vaccine rollouts

Mpox persists in England: Strong vaccine effectiveness, stay vigilant

WHO calls for manufacturers to submit mpox diagnostic tests for Emergency Use Listing

Healthcare workers unprepared for mpox outbreak due to knowledge gaps and vaccine inequity

WHO launches global plan to stop human-to-human transmission of mpox

New Mpox strain sparks global health alert

Responding to Mpox: Global outbreak, research innovations, and therapeutic strategies

First meeting of the International Health Regulations Emergency Committee reports on mpox surge

Tecovirimat shows no significant impact on mpox lesion duration in DRC study

WHO declares international health emergency as mpox spreads rapidly in Africa

WHO considers declaring mpox outbreak a Public Health Emergency of International Concern

Survey: Most people unaware of cooling center locations despite increasing heat wave frequency

Renewed mpox threat finds public unprepared

Priority pathogens selected for wastewater surveillance during Paris 2024 Olympic and Paralympic Games

New deadly strain of mpox found in DRC could spread exponentially among humans

‘We’re flying blind’: CDC has 1M bird flu tests ready, but experts see repeat of covid missteps

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Mpox

Overview

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in